Markers of insulin resistance in Polycystic ovary syndrome women: An update

被引:42
|
作者
Amisi, Chantal Anifa [1 ]
机构
[1] Univ Campus Biomed Rome, Endocrinol & Diabet Unit, Dept Med, Via Alvaro del Portillo 21, I-00128 Rome, Italy
关键词
Markers; Insulin resistance; Polycystic ovary syndrome; Emerging markers; Impaired glucose tolerance; HOMEOSTASIS MODEL ASSESSMENT; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; GLUCOSE-TOLERANCE TEST; BODY-FAT DISTRIBUTION; BETA-CELL FUNCTION; SERUM-LIPOPROTEIN RATIOS; NECROSIS-FACTOR-ALPHA; TO-HEIGHT RATIO;
D O I
10.4239/wjd.v13.i3.129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5%-10% of women of reproductive age. The importance of this syndrome lies in the magnitude of associated comorbidities: infertility, metabolic dysfunction, cardiovascular disease (CVD), plus psychological and oncological complications. Insulin resistance (IR) is a prominent feature of PCOS with a prevalence of 35%-80%. Without adequate management, IR with compensatory hyperinsulinemia contributes directly to reproductive dysfunction in women with PCOS. Furthermore, epidemiological data shows compelling evidence that PCOS is associated with an increased risk of impaired glucose tolerance, gestational diabetes mellitus and type 2 diabetes. In addition, metabolic dysfunction leads to a risk for CVD that increases with aging in women with PCOS. Indeed, the severity of IR in women with PCOS is associated with the amount of abdominal obesity, even in lean women with PCOS. Given these drastic implications, it is important to diagnose and treat insulin resistance as early as possible. Many markers have been proposed. However, quantitative assessment of IR in clinical practice remains a major challenge. The gold standard method for assessing insulin sensitivity is the hyperinsulinemic euglycemic glucose clamp. However, it is not used routinely because of the complexity of its procedure. Consequently, there has been an urgent need for surrogate markers of IR that are more applicable in large population-based epidemiological investigations. Despite this, many of them are either difficult to apply in routine clinical practice or useless for women with PCOS. Considering this difficulty, there is still a need for an accurate marker for easy, early detection and assessment of IR in women with PCOS. This review highlights markers of IR already used in women with PCOS, including new markers recently reported in literature, and it establishes a new classification for these markers.
引用
收藏
页码:129 / 149
页数:21
相关论文
共 50 条
  • [1] Insulin resistance in women: polycystic ovary syndrome
    Kalantaridou, S.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 : 72 - 73
  • [2] Insulin resistance in women with polycystic ovary syndrome
    Dunaif, Andrea
    [J]. FERTILITY AND STERILITY, 2006, 86 : S13 - S14
  • [3] Cardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistance
    Martins, Wellington de Paula
    Soares, Gustavo Mafaldo
    Vieira, Carolina Sales
    dos Reis, Rosana Maria
    Silva de Sa, Marcos Felipe
    Ferriani, Rui Alberto
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2009, 31 (03): : 111 - 116
  • [4] Markers of insulin resistance and metabolic syndrome in polycystic ovary
    Trimeche, S.
    Safer, M. Abid
    Chaieb, M. Chadli
    Ajina, M. Zaouali
    Elghezal, R. Braham
    Beizig, A. Maaroufi
    Ach, K.
    Njah, M. Kacem
    Chaieb, L.
    [J]. DIABETES & METABOLISM, 2011, 37 : A70 - A70
  • [5] New markers of insulin resistance in polycystic ovary syndrome
    Polak, K.
    Czyzyk, A.
    Simoncini, T.
    Meczekalski, B.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (01): : 1 - 8
  • [6] New markers of insulin resistance in polycystic ovary syndrome
    K. Polak
    A. Czyzyk
    T. Simoncini
    B. Meczekalski
    [J]. Journal of Endocrinological Investigation, 2017, 40 : 1 - 8
  • [7] Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome
    Hong, So-hyeon
    Sung, Yeon-Ah
    Hong, Young Sun
    Jeong, Kyungah
    Chung, Hyewon
    Lee, Hyejin
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 87 (04) : 375 - 380
  • [8] Obesity and insulin resistance in women with polycystic ovary syndrome
    Hsu Chun-Sen
    Wu Chien-Hua
    Chiu Wan-Chun
    Lee Ching-Tzu
    Chang Chun-Jen
    Hsu Ming-, I
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (05) : 300 - 306
  • [9] Vascular insulin resistance in women with polycystic ovary syndrome
    Kelly, C
    Spiers, A
    Petrie, J
    Lyall, H
    Gould, G
    Connell, J
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S8 - S8
  • [10] Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome
    Tziomalos, Konstantinos
    Katsikis, Ilias
    Papadakis, Efstathios
    Kandaraki, Eleni A.
    Macut, Djuro
    Panidis, Dimitrios
    [J]. HUMAN REPRODUCTION, 2013, 28 (03) : 785 - 793